nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—Estropipate—osteoporosis	0.114	0.209	CbGbCtD
Rifabutin—CYP3A4—Estropipate—osteoporosis	0.06	0.11	CbGbCtD
Rifabutin—CYP3A4—Calcitriol—osteoporosis	0.06	0.11	CbGbCtD
Rifabutin—CYP1A2—Conjugated Estrogens—osteoporosis	0.0542	0.099	CbGbCtD
Rifabutin—CYP3A4—Ergocalciferol—osteoporosis	0.048	0.0877	CbGbCtD
Rifabutin—CYP1A2—Estradiol—osteoporosis	0.0475	0.0869	CbGbCtD
Rifabutin—CYP3A4—Raloxifene—osteoporosis	0.04	0.0732	CbGbCtD
Rifabutin—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0387	0.0707	CbGbCtD
Rifabutin—CYP3A4—Cholecalciferol—osteoporosis	0.0309	0.0565	CbGbCtD
Rifabutin—CYP3A4—Conjugated Estrogens—osteoporosis	0.0284	0.0519	CbGbCtD
Rifabutin—CYP3A4—Estradiol—osteoporosis	0.0249	0.0455	CbGbCtD
Rifabutin—Dyspepsia—Raloxifene—osteoporosis	0.000596	0.00231	CcSEcCtD
Rifabutin—Hypersensitivity—Etidronic acid—osteoporosis	0.000596	0.00231	CcSEcCtD
Rifabutin—Anaemia—Pamidronate—osteoporosis	0.000595	0.00231	CcSEcCtD
Rifabutin—Insomnia—Calcitriol—osteoporosis	0.000594	0.0023	CcSEcCtD
Rifabutin—Dyspepsia—Ibandronate—osteoporosis	0.00059	0.00229	CcSEcCtD
Rifabutin—Pain—Alendronate—osteoporosis	0.000589	0.00228	CcSEcCtD
Rifabutin—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000588	0.00228	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000587	0.00228	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000585	0.00227	CcSEcCtD
Rifabutin—Decreased appetite—Ibandronate—osteoporosis	0.000583	0.00226	CcSEcCtD
Rifabutin—Pain—Raloxifene—osteoporosis	0.000579	0.00224	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000579	0.00224	CcSEcCtD
Rifabutin—Chest pain—Risedronate—osteoporosis	0.000577	0.00223	CcSEcCtD
Rifabutin—Arthralgia—Risedronate—osteoporosis	0.000577	0.00223	CcSEcCtD
Rifabutin—Myalgia—Risedronate—osteoporosis	0.000577	0.00223	CcSEcCtD
Rifabutin—Leukopenia—Pamidronate—osteoporosis	0.000576	0.00223	CcSEcCtD
Rifabutin—Dysgeusia—Zoledronate—osteoporosis	0.000576	0.00223	CcSEcCtD
Rifabutin—Pain—Ibandronate—osteoporosis	0.000574	0.00222	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000573	0.00222	CcSEcCtD
Rifabutin—Pruritus—Etidronic acid—osteoporosis	0.000572	0.00222	CcSEcCtD
Rifabutin—Gastrointestinal pain—Estropipate—osteoporosis	0.000572	0.00222	CcSEcCtD
Rifabutin—Decreased appetite—Calcitriol—osteoporosis	0.000571	0.00221	CcSEcCtD
Rifabutin—Feeling abnormal—Alendronate—osteoporosis	0.000568	0.0022	CcSEcCtD
Rifabutin—Jaundice—Estradiol—osteoporosis	0.000565	0.00219	CcSEcCtD
Rifabutin—Gastrointestinal pain—Alendronate—osteoporosis	0.000563	0.00218	CcSEcCtD
Rifabutin—Pain—Calcitriol—osteoporosis	0.000561	0.00218	CcSEcCtD
Rifabutin—Flatulence—Conjugated Estrogens—osteoporosis	0.000558	0.00216	CcSEcCtD
Rifabutin—Convulsion—Pamidronate—osteoporosis	0.000558	0.00216	CcSEcCtD
Rifabutin—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000555	0.00215	CcSEcCtD
Rifabutin—Gastrointestinal pain—Raloxifene—osteoporosis	0.000554	0.00215	CcSEcCtD
Rifabutin—Diarrhoea—Etidronic acid—osteoporosis	0.000553	0.00214	CcSEcCtD
Rifabutin—Abdominal pain—Estropipate—osteoporosis	0.000553	0.00214	CcSEcCtD
Rifabutin—Body temperature increased—Estropipate—osteoporosis	0.000553	0.00214	CcSEcCtD
Rifabutin—Feeling abnormal—Ibandronate—osteoporosis	0.000553	0.00214	CcSEcCtD
Rifabutin—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000551	0.00213	CcSEcCtD
Rifabutin—Hepatobiliary disease—Estradiol—osteoporosis	0.000548	0.00213	CcSEcCtD
Rifabutin—Gastrointestinal pain—Ibandronate—osteoporosis	0.000548	0.00213	CcSEcCtD
Rifabutin—Arthralgia—Pamidronate—osteoporosis	0.000548	0.00212	CcSEcCtD
Rifabutin—Myalgia—Pamidronate—osteoporosis	0.000548	0.00212	CcSEcCtD
Rifabutin—Body temperature increased—Alendronate—osteoporosis	0.000545	0.00211	CcSEcCtD
Rifabutin—Abdominal pain—Alendronate—osteoporosis	0.000545	0.00211	CcSEcCtD
Rifabutin—Shock—Risedronate—osteoporosis	0.000544	0.00211	CcSEcCtD
Rifabutin—Anaemia—Zoledronate—osteoporosis	0.000544	0.00211	CcSEcCtD
Rifabutin—Skin disorder—Risedronate—osteoporosis	0.000537	0.00208	CcSEcCtD
Rifabutin—Gastrointestinal pain—Calcitriol—osteoporosis	0.000537	0.00208	CcSEcCtD
Rifabutin—Abdominal pain—Raloxifene—osteoporosis	0.000536	0.00208	CcSEcCtD
Rifabutin—Body temperature increased—Raloxifene—osteoporosis	0.000536	0.00208	CcSEcCtD
Rifabutin—Abdominal pain—Ibandronate—osteoporosis	0.00053	0.00205	CcSEcCtD
Rifabutin—Body temperature increased—Ibandronate—osteoporosis	0.00053	0.00205	CcSEcCtD
Rifabutin—Confusional state—Pamidronate—osteoporosis	0.00053	0.00205	CcSEcCtD
Rifabutin—Leukopenia—Zoledronate—osteoporosis	0.000526	0.00204	CcSEcCtD
Rifabutin—Hepatitis—Estradiol—osteoporosis	0.000521	0.00202	CcSEcCtD
Rifabutin—Abdominal pain—Calcitriol—osteoporosis	0.000519	0.00201	CcSEcCtD
Rifabutin—Body temperature increased—Calcitriol—osteoporosis	0.000519	0.00201	CcSEcCtD
Rifabutin—Shock—Pamidronate—osteoporosis	0.000517	0.002	CcSEcCtD
Rifabutin—Hypersensitivity—Estropipate—osteoporosis	0.000515	0.002	CcSEcCtD
Rifabutin—Thrombocytopenia—Pamidronate—osteoporosis	0.000514	0.00199	CcSEcCtD
Rifabutin—Vomiting—Etidronic acid—osteoporosis	0.000514	0.00199	CcSEcCtD
Rifabutin—Connective tissue disorder—Estradiol—osteoporosis	0.000512	0.00198	CcSEcCtD
Rifabutin—Rash—Etidronic acid—osteoporosis	0.00051	0.00198	CcSEcCtD
Rifabutin—Convulsion—Zoledronate—osteoporosis	0.00051	0.00197	CcSEcCtD
Rifabutin—Dermatitis—Etidronic acid—osteoporosis	0.000509	0.00197	CcSEcCtD
Rifabutin—Hypersensitivity—Alendronate—osteoporosis	0.000508	0.00197	CcSEcCtD
Rifabutin—Headache—Etidronic acid—osteoporosis	0.000506	0.00196	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000504	0.00195	CcSEcCtD
Rifabutin—Asthenia—Estropipate—osteoporosis	0.000502	0.00194	CcSEcCtD
Rifabutin—Anorexia—Pamidronate—osteoporosis	0.000501	0.00194	CcSEcCtD
Rifabutin—Chest pain—Zoledronate—osteoporosis	0.000501	0.00194	CcSEcCtD
Rifabutin—Myalgia—Zoledronate—osteoporosis	0.000501	0.00194	CcSEcCtD
Rifabutin—Arthralgia—Zoledronate—osteoporosis	0.000501	0.00194	CcSEcCtD
Rifabutin—Insomnia—Risedronate—osteoporosis	0.0005	0.00194	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000497	0.00193	CcSEcCtD
Rifabutin—Paraesthesia—Risedronate—osteoporosis	0.000496	0.00192	CcSEcCtD
Rifabutin—Pruritus—Estropipate—osteoporosis	0.000495	0.00192	CcSEcCtD
Rifabutin—Asthenia—Alendronate—osteoporosis	0.000494	0.00192	CcSEcCtD
Rifabutin—Hypersensitivity—Ibandronate—osteoporosis	0.000494	0.00191	CcSEcCtD
Rifabutin—Dyspnoea—Risedronate—osteoporosis	0.000493	0.00191	CcSEcCtD
Rifabutin—Convulsion—Conjugated Estrogens—osteoporosis	0.000491	0.0019	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000489	0.0019	CcSEcCtD
Rifabutin—Pruritus—Alendronate—osteoporosis	0.000487	0.00189	CcSEcCtD
Rifabutin—Dyspepsia—Risedronate—osteoporosis	0.000487	0.00189	CcSEcCtD
Rifabutin—Eye disorder—Estradiol—osteoporosis	0.000487	0.00189	CcSEcCtD
Rifabutin—Confusional state—Zoledronate—osteoporosis	0.000484	0.00188	CcSEcCtD
Rifabutin—Hypersensitivity—Calcitriol—osteoporosis	0.000484	0.00187	CcSEcCtD
Rifabutin—Myalgia—Conjugated Estrogens—osteoporosis	0.000482	0.00187	CcSEcCtD
Rifabutin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000482	0.00187	CcSEcCtD
Rifabutin—Chest pain—Conjugated Estrogens—osteoporosis	0.000482	0.00187	CcSEcCtD
Rifabutin—Asthenia—Ibandronate—osteoporosis	0.000481	0.00186	CcSEcCtD
Rifabutin—Nausea—Etidronic acid—osteoporosis	0.00048	0.00186	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000479	0.00186	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000479	0.00185	CcSEcCtD
Rifabutin—Diarrhoea—Estropipate—osteoporosis	0.000479	0.00185	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Risedronate—osteoporosis	0.000477	0.00185	CcSEcCtD
Rifabutin—Insomnia—Pamidronate—osteoporosis	0.000475	0.00184	CcSEcCtD
Rifabutin—Pruritus—Ibandronate—osteoporosis	0.000475	0.00184	CcSEcCtD
Rifabutin—Pain—Risedronate—osteoporosis	0.000473	0.00183	CcSEcCtD
Rifabutin—Shock—Zoledronate—osteoporosis	0.000472	0.00183	CcSEcCtD
Rifabutin—Paraesthesia—Pamidronate—osteoporosis	0.000472	0.00183	CcSEcCtD
Rifabutin—Diarrhoea—Alendronate—osteoporosis	0.000471	0.00183	CcSEcCtD
Rifabutin—Asthenia—Calcitriol—osteoporosis	0.000471	0.00183	CcSEcCtD
Rifabutin—Immune system disorder—Estradiol—osteoporosis	0.00047	0.00182	CcSEcCtD
Rifabutin—Thrombocytopenia—Zoledronate—osteoporosis	0.00047	0.00182	CcSEcCtD
Rifabutin—Dyspnoea—Pamidronate—osteoporosis	0.000468	0.00182	CcSEcCtD
Rifabutin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000467	0.00181	CcSEcCtD
Rifabutin—Skin disorder—Zoledronate—osteoporosis	0.000466	0.00181	CcSEcCtD
Rifabutin—Pruritus—Calcitriol—osteoporosis	0.000465	0.0018	CcSEcCtD
Rifabutin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000464	0.0018	CcSEcCtD
Rifabutin—Diarrhoea—Raloxifene—osteoporosis	0.000464	0.0018	CcSEcCtD
Rifabutin—Dyspepsia—Pamidronate—osteoporosis	0.000463	0.00179	CcSEcCtD
Rifabutin—Diarrhoea—Ibandronate—osteoporosis	0.000459	0.00178	CcSEcCtD
Rifabutin—Anorexia—Zoledronate—osteoporosis	0.000458	0.00177	CcSEcCtD
Rifabutin—Decreased appetite—Pamidronate—osteoporosis	0.000457	0.00177	CcSEcCtD
Rifabutin—Shock—Conjugated Estrogens—osteoporosis	0.000455	0.00176	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000454	0.00176	CcSEcCtD
Rifabutin—Gastrointestinal pain—Risedronate—osteoporosis	0.000452	0.00175	CcSEcCtD
Rifabutin—Pain—Pamidronate—osteoporosis	0.000449	0.00174	CcSEcCtD
Rifabutin—Diarrhoea—Calcitriol—osteoporosis	0.000449	0.00174	CcSEcCtD
Rifabutin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000449	0.00174	CcSEcCtD
Rifabutin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000448	0.00174	CcSEcCtD
Rifabutin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000448	0.00174	CcSEcCtD
Rifabutin—Flatulence—Estradiol—osteoporosis	0.000447	0.00173	CcSEcCtD
Rifabutin—Vomiting—Estropipate—osteoporosis	0.000445	0.00172	CcSEcCtD
Rifabutin—Dysgeusia—Estradiol—osteoporosis	0.000444	0.00172	CcSEcCtD
Rifabutin—Rash—Estropipate—osteoporosis	0.000441	0.00171	CcSEcCtD
Rifabutin—Dermatitis—Estropipate—osteoporosis	0.000441	0.00171	CcSEcCtD
Rifabutin—Anorexia—Conjugated Estrogens—osteoporosis	0.000441	0.00171	CcSEcCtD
Rifabutin—Headache—Estropipate—osteoporosis	0.000438	0.0017	CcSEcCtD
Rifabutin—Vomiting—Alendronate—osteoporosis	0.000438	0.0017	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000437	0.00169	CcSEcCtD
Rifabutin—Body temperature increased—Risedronate—osteoporosis	0.000437	0.00169	CcSEcCtD
Rifabutin—Abdominal pain—Risedronate—osteoporosis	0.000437	0.00169	CcSEcCtD
Rifabutin—Rash—Alendronate—osteoporosis	0.000434	0.00168	CcSEcCtD
Rifabutin—Insomnia—Zoledronate—osteoporosis	0.000434	0.00168	CcSEcCtD
Rifabutin—Dermatitis—Alendronate—osteoporosis	0.000434	0.00168	CcSEcCtD
Rifabutin—Feeling abnormal—Pamidronate—osteoporosis	0.000433	0.00168	CcSEcCtD
Rifabutin—Headache—Alendronate—osteoporosis	0.000432	0.00167	CcSEcCtD
Rifabutin—Paraesthesia—Zoledronate—osteoporosis	0.000431	0.00167	CcSEcCtD
Rifabutin—Vomiting—Raloxifene—osteoporosis	0.000431	0.00167	CcSEcCtD
Rifabutin—Gastrointestinal pain—Pamidronate—osteoporosis	0.00043	0.00166	CcSEcCtD
Rifabutin—Dyspnoea—Zoledronate—osteoporosis	0.000428	0.00166	CcSEcCtD
Rifabutin—Rash—Raloxifene—osteoporosis	0.000427	0.00166	CcSEcCtD
Rifabutin—Dermatitis—Raloxifene—osteoporosis	0.000427	0.00165	CcSEcCtD
Rifabutin—Vomiting—Ibandronate—osteoporosis	0.000426	0.00165	CcSEcCtD
Rifabutin—Headache—Raloxifene—osteoporosis	0.000424	0.00164	CcSEcCtD
Rifabutin—Rash—Ibandronate—osteoporosis	0.000423	0.00164	CcSEcCtD
Rifabutin—Dermatitis—Ibandronate—osteoporosis	0.000423	0.00164	CcSEcCtD
Rifabutin—Dyspepsia—Zoledronate—osteoporosis	0.000422	0.00164	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000421	0.00163	CcSEcCtD
Rifabutin—Headache—Ibandronate—osteoporosis	0.00042	0.00163	CcSEcCtD
Rifabutin—Insomnia—Conjugated Estrogens—osteoporosis	0.000418	0.00162	CcSEcCtD
Rifabutin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000418	0.00162	CcSEcCtD
Rifabutin—Vomiting—Calcitriol—osteoporosis	0.000417	0.00162	CcSEcCtD
Rifabutin—Decreased appetite—Zoledronate—osteoporosis	0.000417	0.00162	CcSEcCtD
Rifabutin—Nausea—Estropipate—osteoporosis	0.000415	0.00161	CcSEcCtD
Rifabutin—Abdominal pain—Pamidronate—osteoporosis	0.000415	0.00161	CcSEcCtD
Rifabutin—Body temperature increased—Pamidronate—osteoporosis	0.000415	0.00161	CcSEcCtD
Rifabutin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000415	0.00161	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000414	0.00161	CcSEcCtD
Rifabutin—Rash—Calcitriol—osteoporosis	0.000414	0.0016	CcSEcCtD
Rifabutin—Dermatitis—Calcitriol—osteoporosis	0.000414	0.0016	CcSEcCtD
Rifabutin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000412	0.0016	CcSEcCtD
Rifabutin—Headache—Calcitriol—osteoporosis	0.000411	0.00159	CcSEcCtD
Rifabutin—Pain—Zoledronate—osteoporosis	0.00041	0.00159	CcSEcCtD
Rifabutin—Nausea—Alendronate—osteoporosis	0.000409	0.00159	CcSEcCtD
Rifabutin—Hypersensitivity—Risedronate—osteoporosis	0.000407	0.00158	CcSEcCtD
Rifabutin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000407	0.00158	CcSEcCtD
Rifabutin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000407	0.00158	CcSEcCtD
Rifabutin—Nausea—Raloxifene—osteoporosis	0.000402	0.00156	CcSEcCtD
Rifabutin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000402	0.00156	CcSEcCtD
Rifabutin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000401	0.00155	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000399	0.00155	CcSEcCtD
Rifabutin—Nausea—Ibandronate—osteoporosis	0.000398	0.00154	CcSEcCtD
Rifabutin—Asthenia—Risedronate—osteoporosis	0.000397	0.00154	CcSEcCtD
Rifabutin—Feeling abnormal—Zoledronate—osteoporosis	0.000396	0.00153	CcSEcCtD
Rifabutin—Pain—Conjugated Estrogens—osteoporosis	0.000395	0.00153	CcSEcCtD
Rifabutin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000392	0.00152	CcSEcCtD
Rifabutin—Pruritus—Risedronate—osteoporosis	0.000391	0.00152	CcSEcCtD
Rifabutin—Nausea—Calcitriol—osteoporosis	0.00039	0.00151	CcSEcCtD
Rifabutin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000388	0.0015	CcSEcCtD
Rifabutin—Hypersensitivity—Pamidronate—osteoporosis	0.000387	0.0015	CcSEcCtD
Rifabutin—Arthralgia—Estradiol—osteoporosis	0.000386	0.0015	CcSEcCtD
Rifabutin—Myalgia—Estradiol—osteoporosis	0.000386	0.0015	CcSEcCtD
Rifabutin—Chest pain—Estradiol—osteoporosis	0.000386	0.0015	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000383	0.00148	CcSEcCtD
Rifabutin—Abdominal pain—Zoledronate—osteoporosis	0.000379	0.00147	CcSEcCtD
Rifabutin—Body temperature increased—Zoledronate—osteoporosis	0.000379	0.00147	CcSEcCtD
Rifabutin—Diarrhoea—Risedronate—osteoporosis	0.000378	0.00147	CcSEcCtD
Rifabutin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000378	0.00146	CcSEcCtD
Rifabutin—Asthenia—Pamidronate—osteoporosis	0.000377	0.00146	CcSEcCtD
Rifabutin—Confusional state—Estradiol—osteoporosis	0.000373	0.00145	CcSEcCtD
Rifabutin—Pruritus—Pamidronate—osteoporosis	0.000372	0.00144	CcSEcCtD
Rifabutin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000365	0.00142	CcSEcCtD
Rifabutin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000365	0.00142	CcSEcCtD
Rifabutin—Shock—Estradiol—osteoporosis	0.000364	0.00141	CcSEcCtD
Rifabutin—Vomiting—Ethinyl Estradiol—osteoporosis	0.00036	0.0014	CcSEcCtD
Rifabutin—Diarrhoea—Pamidronate—osteoporosis	0.00036	0.00139	CcSEcCtD
Rifabutin—Skin disorder—Estradiol—osteoporosis	0.000359	0.00139	CcSEcCtD
Rifabutin—Rash—Ethinyl Estradiol—osteoporosis	0.000357	0.00139	CcSEcCtD
Rifabutin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000357	0.00138	CcSEcCtD
Rifabutin—Headache—Ethinyl Estradiol—osteoporosis	0.000355	0.00138	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—IRS2—osteoporosis	0.000355	0.00182	CbGpPWpGaD
Rifabutin—Hypersensitivity—Zoledronate—osteoporosis	0.000354	0.00137	CcSEcCtD
Rifabutin—Vomiting—Risedronate—osteoporosis	0.000351	0.00136	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—IRS2—osteoporosis	0.00035	0.0018	CbGpPWpGaD
Rifabutin—Rash—Risedronate—osteoporosis	0.000349	0.00135	CcSEcCtD
Rifabutin—Dermatitis—Risedronate—osteoporosis	0.000348	0.00135	CcSEcCtD
Rifabutin—Headache—Risedronate—osteoporosis	0.000346	0.00134	CcSEcCtD
Rifabutin—HSP90AA1—Disease—PKM—osteoporosis	0.000345	0.00177	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SOST—osteoporosis	0.000345	0.00177	CbGpPWpGaD
Rifabutin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000345	0.00177	CbGpPWpGaD
Rifabutin—Asthenia—Zoledronate—osteoporosis	0.000344	0.00133	CcSEcCtD
Rifabutin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000343	0.00176	CbGpPWpGaD
Rifabutin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00034	0.00132	CcSEcCtD
Rifabutin—Pruritus—Zoledronate—osteoporosis	0.00034	0.00132	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000337	0.00131	CcSEcCtD
Rifabutin—Nausea—Ethinyl Estradiol—osteoporosis	0.000337	0.0013	CcSEcCtD
Rifabutin—Insomnia—Estradiol—osteoporosis	0.000335	0.0013	CcSEcCtD
Rifabutin—Vomiting—Pamidronate—osteoporosis	0.000334	0.00129	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—IRS1—osteoporosis	0.000332	0.0017	CbGpPWpGaD
Rifabutin—Paraesthesia—Estradiol—osteoporosis	0.000332	0.00129	CcSEcCtD
Rifabutin—Asthenia—Conjugated Estrogens—osteoporosis	0.000332	0.00128	CcSEcCtD
Rifabutin—Rash—Pamidronate—osteoporosis	0.000331	0.00128	CcSEcCtD
Rifabutin—Dermatitis—Pamidronate—osteoporosis	0.000331	0.00128	CcSEcCtD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—MYC—osteoporosis	0.00033	0.00169	CbGpPWpGaD
Rifabutin—Dyspnoea—Estradiol—osteoporosis	0.00033	0.00128	CcSEcCtD
Rifabutin—Headache—Pamidronate—osteoporosis	0.000329	0.00128	CcSEcCtD
Rifabutin—Diarrhoea—Zoledronate—osteoporosis	0.000328	0.00127	CcSEcCtD
Rifabutin—Nausea—Risedronate—osteoporosis	0.000328	0.00127	CcSEcCtD
Rifabutin—HSP90AA1—Disease—PGLS—osteoporosis	0.000327	0.00168	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ANTXR2—osteoporosis	0.000327	0.00168	CbGpPWpGaD
Rifabutin—Pruritus—Conjugated Estrogens—osteoporosis	0.000327	0.00127	CcSEcCtD
Rifabutin—Dyspepsia—Estradiol—osteoporosis	0.000326	0.00126	CcSEcCtD
Rifabutin—Decreased appetite—Estradiol—osteoporosis	0.000322	0.00125	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000319	0.00124	CcSEcCtD
Rifabutin—Pain—Estradiol—osteoporosis	0.000316	0.00123	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—WNT1—osteoporosis	0.000316	0.00162	CbGpPWpGaD
Rifabutin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000316	0.00123	CcSEcCtD
Rifabutin—Nausea—Pamidronate—osteoporosis	0.000312	0.00121	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—IL6R—osteoporosis	0.000312	0.0016	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—IRS1—osteoporosis	0.000309	0.00159	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—SOD2—osteoporosis	0.000309	0.00158	CbGpPWpGaD
Rifabutin—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	0.000308	0.00158	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—IRS1—osteoporosis	0.000305	0.00157	CbGpPWpGaD
Rifabutin—Vomiting—Zoledronate—osteoporosis	0.000305	0.00118	CcSEcCtD
Rifabutin—Feeling abnormal—Estradiol—osteoporosis	0.000305	0.00118	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—LEP—osteoporosis	0.000303	0.00156	CbGpPWpGaD
Rifabutin—Rash—Zoledronate—osteoporosis	0.000303	0.00117	CcSEcCtD
Rifabutin—Gastrointestinal pain—Estradiol—osteoporosis	0.000302	0.00117	CcSEcCtD
Rifabutin—Dermatitis—Zoledronate—osteoporosis	0.000302	0.00117	CcSEcCtD
Rifabutin—HSP90B1—Immune System—KL—osteoporosis	0.000301	0.00155	CbGpPWpGaD
Rifabutin—Headache—Zoledronate—osteoporosis	0.000301	0.00117	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—CTSK—osteoporosis	0.000297	0.00152	CbGpPWpGaD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000297	0.00152	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—GPX1—osteoporosis	0.000295	0.00151	CbGpPWpGaD
Rifabutin—Vomiting—Conjugated Estrogens—osteoporosis	0.000294	0.00114	CcSEcCtD
Rifabutin—Body temperature increased—Estradiol—osteoporosis	0.000292	0.00113	CcSEcCtD
Rifabutin—Abdominal pain—Estradiol—osteoporosis	0.000292	0.00113	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—NFATC1—osteoporosis	0.000292	0.0015	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—TGFB1—osteoporosis	0.000291	0.0015	CbGpPWpGaD
Rifabutin—Rash—Conjugated Estrogens—osteoporosis	0.000291	0.00113	CcSEcCtD
Rifabutin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000291	0.00113	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—IL6R—osteoporosis	0.000291	0.00149	CbGpPWpGaD
Rifabutin—Headache—Conjugated Estrogens—osteoporosis	0.00029	0.00112	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—PKM—osteoporosis	0.000289	0.00148	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—FDPS—osteoporosis	0.000289	0.00148	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—IL6R—osteoporosis	0.000287	0.00147	CbGpPWpGaD
Rifabutin—Nausea—Zoledronate—osteoporosis	0.000285	0.0011	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.00028	0.00144	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.00028	0.00144	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—GSN—osteoporosis	0.000278	0.00143	CbGpPWpGaD
Rifabutin—Nausea—Conjugated Estrogens—osteoporosis	0.000275	0.00106	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—GPD2—osteoporosis	0.000274	0.00141	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PGLS—osteoporosis	0.000274	0.00141	CbGpPWpGaD
Rifabutin—Hypersensitivity—Estradiol—osteoporosis	0.000273	0.00106	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—TNF—osteoporosis	0.000272	0.0014	CbGpPWpGaD
Rifabutin—Asthenia—Estradiol—osteoporosis	0.000265	0.00103	CcSEcCtD
Rifabutin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000265	0.00136	CbGpPWpGaD
Rifabutin—Pruritus—Estradiol—osteoporosis	0.000262	0.00101	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—POMC—osteoporosis	0.00026	0.00134	CbGpPWpGaD
Rifabutin—Diarrhoea—Estradiol—osteoporosis	0.000253	0.000981	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—ATIC—osteoporosis	0.000251	0.00129	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PNP—osteoporosis	0.000251	0.00129	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—IGF1—osteoporosis	0.000251	0.00129	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—PSMA5—osteoporosis	0.00025	0.00128	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—PSMA2—osteoporosis	0.00025	0.00128	CbGpPWpGaD
Rifabutin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000249	0.00128	CbGpPWpGaD
Rifabutin—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000246	0.00126	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—LRP5—osteoporosis	0.000242	0.00124	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SOST—osteoporosis	0.000242	0.00124	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	0.000241	0.00124	CbGpPWpGaD
Rifabutin—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000238	0.00122	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—AGER—osteoporosis	0.000237	0.00122	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—ADCY5—osteoporosis	0.000236	0.00121	CbGpPWpGaD
Rifabutin—Vomiting—Estradiol—osteoporosis	0.000235	0.000911	CcSEcCtD
Rifabutin—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	0.000235	0.0012	CbGpPWpGaD
Rifabutin—Rash—Estradiol—osteoporosis	0.000233	0.000904	CcSEcCtD
Rifabutin—Dermatitis—Estradiol—osteoporosis	0.000233	0.000903	CcSEcCtD
Rifabutin—Headache—Estradiol—osteoporosis	0.000232	0.000898	CcSEcCtD
Rifabutin—HSP90AA1—Disease—LRP6—osteoporosis	0.000231	0.00119	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IRAK3—osteoporosis	0.000228	0.00117	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—LTF—osteoporosis	0.000222	0.00114	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—RPL24—osteoporosis	0.000222	0.00114	CbGpPWpGaD
Rifabutin—Nausea—Estradiol—osteoporosis	0.00022	0.000851	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—IL6—osteoporosis	0.00022	0.00113	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CALCR—osteoporosis	0.000219	0.00112	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTH1R—osteoporosis	0.000219	0.00112	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—OXCT1—osteoporosis	0.000213	0.00109	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CA2—osteoporosis	0.000213	0.00109	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ACTG1—osteoporosis	0.000209	0.00107	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—MGLL—osteoporosis	0.000208	0.00107	CbGpPWpGaD
Rifabutin—HSP90AA1—Influenza Infection—TGFB1—osteoporosis	0.000207	0.00106	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IRS2—osteoporosis	0.000206	0.00106	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000206	0.00106	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	0.000204	0.00105	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—KL—osteoporosis	0.000202	0.00104	CbGpPWpGaD
Rifabutin—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000202	0.00104	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—TGFB1—osteoporosis	0.000201	0.00103	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	0.000201	0.00103	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—IL6—osteoporosis	0.000195	0.000999	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ACP5—osteoporosis	0.000193	0.000989	CbGpPWpGaD
Rifabutin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000192	0.000986	CbGpPWpGaD
Rifabutin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.00019	0.000973	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—IL6—osteoporosis	0.000184	0.000943	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IRS1—osteoporosis	0.00018	0.000925	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—IL6R—osteoporosis	0.00018	0.000924	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TPI1—osteoporosis	0.000179	0.00092	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—IDH2—osteoporosis	0.000177	0.000906	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—RAP1A—osteoporosis	0.000175	0.000895	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MGLL—osteoporosis	0.000174	0.000891	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CTSK—osteoporosis	0.000173	0.000888	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NFATC1—osteoporosis	0.00017	0.000873	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—LRP5—osteoporosis	0.000169	0.000869	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL6R—osteoporosis	0.000169	0.000869	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—P4HB—osteoporosis	0.000169	0.000865	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP27A1—osteoporosis	0.000166	0.000852	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—GAPDH—osteoporosis	0.000165	0.000849	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—LRP6—osteoporosis	0.000162	0.000832	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ACP5—osteoporosis	0.000161	0.000828	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AGER—osteoporosis	0.000159	0.000814	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—ADCY5—osteoporosis	0.000158	0.000812	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000158	0.000808	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NFATC1—osteoporosis	0.000157	0.000806	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—DKK1—osteoporosis	0.000156	0.0008	CbGpPWpGaD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000156	0.000799	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000155	0.000797	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—LEP—osteoporosis	0.000153	0.000787	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—WNT1—osteoporosis	0.00015	0.000771	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—TPI1—osteoporosis	0.00015	0.00077	CbGpPWpGaD
Rifabutin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.00015	0.000768	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FGA—osteoporosis	0.000146	0.00075	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—P4HB—osteoporosis	0.000141	0.000724	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—IL6—osteoporosis	0.000139	0.000713	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PSMA2—osteoporosis	0.000139	0.000713	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PSMA5—osteoporosis	0.000139	0.000713	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GAPDH—osteoporosis	0.000139	0.000711	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IRS2—osteoporosis	0.000138	0.00071	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000137	0.000705	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TLN1—osteoporosis	0.000137	0.000702	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000136	0.0007	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—RAP1A—osteoporosis	0.000135	0.000692	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ENO1—osteoporosis	0.00013	0.000668	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—IL6—osteoporosis	0.00013	0.000664	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000129	0.000664	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL1B—osteoporosis	0.000129	0.000661	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—IL6R—osteoporosis	0.000129	0.000659	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PSMA2—osteoporosis	0.000128	0.000658	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PSMA5—osteoporosis	0.000128	0.000658	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—IL6—osteoporosis	0.000128	0.000656	CbGpPWpGaD
Rifabutin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000121	0.000622	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IRS1—osteoporosis	0.000121	0.00062	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CALCA—osteoporosis	0.00012	0.000614	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—P4HB—osteoporosis	0.000118	0.000605	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KL—osteoporosis	0.000118	0.000603	CbGpPWpGaD
Rifabutin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000116	0.000593	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTH—osteoporosis	0.000115	0.000589	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6R—osteoporosis	0.000114	0.000582	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RAP1A—osteoporosis	0.000113	0.000579	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CNR2—osteoporosis	0.000112	0.000574	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NFATC1—osteoporosis	0.00011	0.000565	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—DKK1—osteoporosis	0.000109	0.00056	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ENO1—osteoporosis	0.000109	0.00056	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KL—osteoporosis	0.000109	0.000557	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PSMA2—osteoporosis	0.000107	0.000551	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PSMA5—osteoporosis	0.000107	0.000551	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	0.000107	0.00055	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000107	0.000549	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000107	0.000548	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	0.000106	0.000543	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—WNT1—osteoporosis	0.000105	0.00054	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FGA—osteoporosis	0.000102	0.000525	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000101	0.000516	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	9.97e-05	0.000511	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	9.97e-05	0.000511	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	9.81e-05	0.000503	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTHLH—osteoporosis	9.51e-05	0.000488	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—BMP2—osteoporosis	9.51e-05	0.000488	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—IL6—osteoporosis	9.45e-05	0.000485	CbGpPWpGaD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.36e-05	0.00048	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FGB—osteoporosis	9.31e-05	0.000478	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AGER—osteoporosis	9.25e-05	0.000474	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ADCY5—osteoporosis	9.21e-05	0.000473	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PSMA5—osteoporosis	8.99e-05	0.000461	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PSMA2—osteoporosis	8.99e-05	0.000461	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP19A1—osteoporosis	8.72e-05	0.000447	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ADCY5—osteoporosis	8.51e-05	0.000436	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CALCA—osteoporosis	8.37e-05	0.00043	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	8.28e-05	0.000425	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	8.16e-05	0.000419	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IRS2—osteoporosis	8.06e-05	0.000414	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—IL6—osteoporosis	8.02e-05	0.000412	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MYC—osteoporosis	7.89e-05	0.000405	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.84e-05	0.000402	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MTHFR—osteoporosis	7.82e-05	0.000401	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KL—osteoporosis	7.6e-05	0.00039	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TGFB1—osteoporosis	7.6e-05	0.00039	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL6—osteoporosis	7.54e-05	0.000387	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IRS2—osteoporosis	7.44e-05	0.000382	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ADCY5—osteoporosis	7.12e-05	0.000366	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GPX1—osteoporosis	7.1e-05	0.000364	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TNF—osteoporosis	7.09e-05	0.000364	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MYC—osteoporosis	7.05e-05	0.000362	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IRS1—osteoporosis	7.04e-05	0.000361	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.67e-05	0.000342	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6R—osteoporosis	6.61e-05	0.000339	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—MTHFR—osteoporosis	6.55e-05	0.000336	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IRS1—osteoporosis	6.5e-05	0.000333	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—POMC—osteoporosis	6.45e-05	0.000331	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6R—osteoporosis	6.1e-05	0.000313	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PKM—osteoporosis	6.08e-05	0.000312	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—FDPS—osteoporosis	6.08e-05	0.000312	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ADCY5—osteoporosis	5.96e-05	0.000306	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SPP1—osteoporosis	5.76e-05	0.000296	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PGLS—osteoporosis	5.76e-05	0.000296	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPD2—osteoporosis	5.76e-05	0.000296	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—IL6—osteoporosis	5.73e-05	0.000294	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ATIC—osteoporosis	5.27e-05	0.00027	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PNP—osteoporosis	5.27e-05	0.00027	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—POMC—osteoporosis	5.24e-05	0.000269	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IRS2—osteoporosis	5.21e-05	0.000267	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—LEP—osteoporosis	5.1e-05	0.000262	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6—osteoporosis	5.06e-05	0.000259	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL1B—osteoporosis	5.03e-05	0.000258	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—POMC—osteoporosis	4.97e-05	0.000255	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ESR1—osteoporosis	4.87e-05	0.00025	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PKM—osteoporosis	4.69e-05	0.000241	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—FDPS—osteoporosis	4.69e-05	0.000241	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IRS1—osteoporosis	4.55e-05	0.000233	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—OXCT1—osteoporosis	4.48e-05	0.00023	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CA2—osteoporosis	4.48e-05	0.00023	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPD2—osteoporosis	4.45e-05	0.000228	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PGLS—osteoporosis	4.45e-05	0.000228	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—POMC—osteoporosis	4.38e-05	0.000225	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MGLL—osteoporosis	4.37e-05	0.000224	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6R—osteoporosis	4.27e-05	0.000219	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IGF1—osteoporosis	4.21e-05	0.000216	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.12e-05	0.000211	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ATIC—osteoporosis	4.07e-05	0.000209	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PNP—osteoporosis	4.07e-05	0.000209	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—IDH2—osteoporosis	3.71e-05	0.000191	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—osteoporosis	3.62e-05	0.000186	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TGFB1—osteoporosis	3.61e-05	0.000185	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP27A1—osteoporosis	3.49e-05	0.000179	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—OXCT1—osteoporosis	3.46e-05	0.000177	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CA2—osteoporosis	3.46e-05	0.000177	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ACP5—osteoporosis	3.4e-05	0.000174	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MGLL—osteoporosis	3.37e-05	0.000173	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.35e-05	0.000172	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TPI1—osteoporosis	3.16e-05	0.000162	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—P4HB—osteoporosis	2.97e-05	0.000152	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6—osteoporosis	2.94e-05	0.000151	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GAPDH—osteoporosis	2.91e-05	0.000149	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—IDH2—osteoporosis	2.87e-05	0.000147	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—RAP1A—osteoporosis	2.84e-05	0.000146	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6—osteoporosis	2.72e-05	0.000139	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.69e-05	0.000138	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ACP5—osteoporosis	2.62e-05	0.000134	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—osteoporosis	2.53e-05	0.00013	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TGFB1—osteoporosis	2.53e-05	0.00013	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.47e-05	0.000127	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TPI1—osteoporosis	2.44e-05	0.000125	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ENO1—osteoporosis	2.29e-05	0.000118	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—P4HB—osteoporosis	2.29e-05	0.000118	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PSMA5—osteoporosis	2.26e-05	0.000116	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PSMA2—osteoporosis	2.26e-05	0.000116	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GAPDH—osteoporosis	2.25e-05	0.000115	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—RAP1A—osteoporosis	2.19e-05	0.000112	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6—osteoporosis	1.9e-05	9.77e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.83e-05	9.41e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ENO1—osteoporosis	1.77e-05	9.08e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PSMA2—osteoporosis	1.74e-05	8.95e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PSMA5—osteoporosis	1.74e-05	8.95e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ADCY5—osteoporosis	1.5e-05	7.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPX1—osteoporosis	1.49e-05	7.66e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.42e-05	7.26e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTHFR—osteoporosis	1.38e-05	7.07e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ADCY5—osteoporosis	1.16e-05	5.93e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPX1—osteoporosis	1.15e-05	5.91e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—POMC—osteoporosis	1.1e-05	5.65e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTHFR—osteoporosis	1.06e-05	5.46e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—POMC—osteoporosis	8.51e-06	4.36e-05	CbGpPWpGaD
